Is adolescent pertussis vaccination preferable to natural booster infections? - Wikidata - awgldk - TriplyDB

Is adolescent pertussis vaccination preferable to natural booster infections?

Is adolescent pertussis vaccination preferable to natural booster infections?

http://www.wikidata.org/entity/Q37960125

about

Pertussis-specific memory B-cell and humoral IgG responses in adolescents after a fifth consecutive dose of acellular pertussis vaccine The social life of infants in the context of infectious disease transmission; social contacts and mixing patterns of the very young.Antibody responses to Bordetella pertussis Fim2 or Fim3 following immunization with a whole-cell, two-component, or five-component acellular pertussis vaccine and following pertussis disease in children in Sweden in 1997 and 2007.Live attenuated vaccines against pertussis.T-cell immune responses to Bordetella pertussis infection and vaccination.Changing from whole-cell to acellular pertussis vaccines would trade superior tolerability for inferior protection.Prevalence of asymptomatic Bordetella pertussis and Bordetella parapertussis infections among school children in China as determined by pooled real-time PCR: a cross-sectional study.Use of acellular pertussis vaccines in the United States: can we do better?

P2860

Q34260834-C66994CB-2678-4773-AED8-3D1C2360D02A Q35022663-E9EFBDA9-93D4-4D83-9984-74BCFB7049F4 Q37545016-84EDA6DD-D8A3-4608-B887-9CDDFF78C1D4 Q38236200-91BCC6B2-C71C-44D2-BF9A-D948E03E2F04 Q38560699-DBBB7160-C419-4B5C-9650-78F8D8100204 Q39065890-119DDE9D-8D72-43A5-BF02-C44B53703D36 Q42228770-E166F4B2-DDF0-4F80-AEE3-3C43A3EE0ABB Q48628546-4DBFEF28-6897-485C-8B7D-6263122DEDC3

P2860

Is adolescent pertussis vaccination preferable to natural booster infections?

http://www.wikidata.org/entity/Q37960125

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

Is adolescent pertussis vaccination preferable to natural booster infections?

@en

Is adolescent pertussis vaccination preferable to natural booster infections?

@nl

type

label

Is adolescent pertussis vaccination preferable to natural booster infections?

@en

Is adolescent pertussis vaccination preferable to natural booster infections?

@nl

prefLabel

Is adolescent pertussis vaccination preferable to natural booster infections?

@en

Is adolescent pertussis vaccination preferable to natural booster infections?

@nl

P1433

Q37960125-8C666C24-2712-4165-A155-14AE00D481AB

P1476

Q37960125-67C508D8-B11A-4EA8-80A2-D60C0E9B3E1B

P2093

Q37960125-8FF4CBC9-3F44-4A50-860F-87286F21F18B

Q37960125-E7411735-B2CA-40A9-89D2-65AF941B69D8

P2860

Q37960125-04F2DC73-A5B2-415A-AC28-15F4EF545B24

Q37960125-100A16E6-1D37-4133-9B06-88A7D13A27DF

Q37960125-16332810-900A-4B54-9E6A-7A5A9A082687

Q37960125-29380670-3961-462F-9DB4-DDCA3FB7AB30

Q37960125-3383C6CA-2710-4D53-91E9-EF2AA49AFC57

Q37960125-3975C8CD-327D-48A9-958E-14E8A9B1B176

Q37960125-695E578B-D15B-4CB1-BB99-67195819459E

Q37960125-6D7DF996-8E02-4607-849F-4CD7040C6CBA

Q37960125-7C28A060-3A21-40C0-B76F-C50BC7EC7B1D

Q37960125-8F9C27C3-F3C7-44C8-BA2C-AC4DC3C3F4D6

P304

Q37960125-F7CD87DB-0A4A-4EC8-B896-C161AEDB5F3F

P31

Q37960125-EA5080A7-62BA-4EC5-AFA7-D5FDE8EF118F

P356

Q37960125-49C53BB1-8E42-419F-AA2C-C71298ED58DA

P407

Q37960125-994B05E9-5AA4-46B4-8B36-7883EA415031

P433

Q37960125-8CBE13C0-4A29-490A-B9C3-118E5E8ED9FC

P478

Q37960125-8AB2E521-AA58-478D-8795-F7096A8B5F27

P50

Q37960125-09FF1A74-F1DD-48D1-ADD9-F386420039D2

P577

Q37960125-12DF6352-E7FD-4DAF-8093-7217E838B545

P698

Q37960125-05191711-282E-4146-BDE2-950AFFDBD960

P921

Q37960125-B716C543-EFD4-4F14-977A-44C490171F0D

P356

P1433

Expert Review of Clinical Pharmacology

P1476

Is adolescent pertussis vaccination preferable to natural booster infections?

@en

P2093

Hans O Hallander

http://www.w3.org/2001/XMLSchema#string

Lennart Gustafsson

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.

Cost-effectiveness of adolescent pertussis vaccination for the Netherlands: using an individual-based dynamic model

Implementation of cocooning against pertussis in a high-risk population.

Rationale for pertussis booster vaccination throughout life in Europe.

Adolescent and adult pertussis vaccination: computer simulations of five new strategies.

Imperfect vaccine-induced immunity and whooping cough transmission to infants

Duration of immunity against pertussis after natural infection or vaccination.

Seroprevalence of pertussis antitoxin (anti-PT) in Sweden before and 10 years after the introduction of a universal childhood pertussis vaccination program.

An adolescent and adult formulation combined tetanus, diphtheria and five-component pertussis vaccine.

The case for maternal vaccination against pertussis.

P304

705-711

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ECP.11.55

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22111856

http://www.w3.org/2001/XMLSchema#string

P921